PBYI

Puma Biotechnology (PBYI)

Puma Biotechnology Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PBYI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/18	05:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBYI	Puma Biotechnology Inc
2024/05/03	05:05	Business Wire	Puma Biotechnology Reports First Quarter Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/04/19	05:15	Business Wire	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/04/04	06:30	Business Wire	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PBYI	Puma Biotechnology Inc
2024/03/20	21:30	Business Wire	Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	NASDAQ:PBYI	Puma Biotechnology Inc
2024/03/01	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBYI	Puma Biotechnology Inc
2024/03/01	06:05	Business Wire	Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/28	08:30	Business Wire	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/23	06:10	Business Wire	Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/16	06:10	Business Wire	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	08:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	08:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/14	22:19	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/13	22:30	Business Wire	Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/07	05:54	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/18	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/12	06:07	Business Wire	Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/11	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/11	06:38	Edgar (US Regulatory)	Form 144/A - Report of proposed sale of securities: [Amend]	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/06	09:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/06	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/06	08:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/06	08:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/04	11:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/04	11:39	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/04	11:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/04	11:34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2023/12/11	22:30	Business Wire	Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	NASDAQ:PBYI	Puma Biotechnology Inc